Yuba City, California, Nov. 01, 2016 -- Signal Bay, Inc. (OTC PINK: SGBY) the market leader in cannabis testing and laboratory services announced today the completion of the purchase of Green Style Analytics Lab in Yuba City, California. This acquisition brings the total number of labs now operating under the EVIO Labs brand to five.
CEO William Waldrop stated, "We are very proud to announce the first of many EVIO Lab locations in the state of California. Green Style Analytics Lab currently services around 1300 accounts throughout Northern California including Humboldt, Trinity and Shasta counties to the north and Placer, Calaveras and Sacramento counties to the south. Founder Catherine Emond and her team have done a tremendous job building relationships with cultivators, processors and dispensaries throughout the region. Founded in 2010, the longevity and sizable client base are both testaments to their efforts in growing the business to date.”
Located one hour north of Sacramento and a little over four hours from our Medford, Oregon location, we know that this new lab provides a strategic position to build out our EVIO Labs spoke & hub throughout California. With the addition of Green Style Analytics, we now have 31 team members working hard to grow EVIO Labs.”
Mr. Waldrop continued, "The California Prop 64 vote is next week and currently polling at over 60% on the Yes side and with the AB266 legislation in place. The timing could not be more favorable for us to enter the California cannabis marketplace.”
Mr. Waldrop also stated, "We would like to thank everyone involved with making this acquisition a success.”
About Signal Bay, Inc.: Signal Bay, Inc. is the Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact: William Waldrop, CEO [email protected] (541) 633-4568


Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 



